Skip to search formSkip to main contentSkip to account menu

notoginsenoside R1

Known as: notoginsenoside R 1 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Ginsenosides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Notoginsenoside R1 protects WI‐38 cells against lipopolysaccharide‐triggered injury via adjusting the miR‐181a/TLR4 axis
Notoginsenoside R1 (NGR1) is a neoteric phytoestrogen extracted from Panax notoginseng, and possesses comprehensive… 
2019
2019
Simultaneous determination of three saponins in human plasma after oral administration of compound danshen dripping pills by LC‐MS/MS and its application in a pharmacokinetic study
2019
2019
Notoginsenoside R1 protects human renal proximal tubular epithelial cells from lipopolysaccharide-stimulated inflammatory damage by up-regulation of miR-26a.
2018
2018
[Effect of microRNA-34a/SIRT1/p53 signal pathway on notoginsenoside R₁ delaying vascular endothelial cell senescence].
This study aimed to investigate the effect of notoginsenoside R₁ in delaying H₂O₂-induced vascular endothelial cell senescence… 
2017
2017
Notoginsenoside R1 attenuates glucose-induced podocyte injury via the inhibition of apoptosis and the activation of autophagy through the PI3K/Akt/mTOR signaling pathway.
Injury to terminally differentiated podocytes contributes ignificantly to proteinuria and glomerulosclerosis. The aim of this… 
2017
2017
[Effect of astragaloside Ⅳ combined with Panax notoginseng saponins on cerebral ischemia-reperfusion injury and study of pharmacokinetics in rats].
The aim is to study the effect of astragaloside Ⅳ (AST Ⅳ) combined with Panax notoginseng saponins (PNS) on cerebral ischemia… 
2015
2015
Notoginsenoside R 1 reduces blood pressure in spontaneously hypertensive rats through a long non-coding RNA AK 094457
Notoginsenoside R1 (NR1) is the main bioactive component in panaxnotoginseng, an old herb medicine widely used in Asian countries… 
2015
2015
[In vivo Pharmacokinetics of Notoginsenoside R1 in Ischemia Rats After Acute Myocardial Infarction].
OBJECTIVE To establish an HPLC-UV method for determining pharmacokinetic difference of notoginsenoside R1 between normal rats and… 
2014
2014
Notoginsenoside R 1 Ameliorates Podocyte Adhesion Under Diabetic Condition Through α 3 β 1 Integrin Upregulation in Vitro and in Vivo
Background: Decreased expression of α3β1 integrin may contribute to reduction in podocyte adhesion to glomerular basement… 
2006
2006
Protection and mechanism of notoginsenoside-Rg_1 on focal cerebral ischemia-reperfusion rats
Objective To explore the effects of notoginsenoside-Rg_1 on brain-derived neurotrophic factor(BDNF) protein in cerebrum cortex of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)